Cargando…
Case report: Allogeneic stem cell transplantation for type B insulin resistance
Type B insulin resistance (TBIR) is a rare, often fulminant form of insulin resistance caused by autoantibodies against the insulin receptor. If left untreated, its mortality is high. Various immunosuppressive regimens have shown efficacy, but treatment effects are variable and time-delayed, and dru...
Autores principales: | Ebert, Thomas, Behre, Gerhard, Weidhase, Lorenz, Vucinic, Vladan, Gewert, Cornelia, Semple, Robert K., Stumvoll, Michael, Tönjes, Anke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495837/ https://www.ncbi.nlm.nih.gov/pubmed/37706022 http://dx.doi.org/10.3389/fmed.2023.1200037 |
Ejemplares similares
-
Allogeneic Hematopoietic Stem Cell Transplantation in a Rare Case of Tonsillar Mast Cell Sarcoma
por: Kubasch, Anne Sophie, et al.
Publicado: (2020) -
Type B Insulin Resistance Masquerading as Ovarian
Hyperthecosis
por: Brown, Rebecca J., et al.
Publicado: (2016) -
Case Report: Allogeneic Stem Cell Transplantation Following Induction With CPX-351 in Patients With Acute Myeloid Leukemia Is Feasible
por: Vucinic, Vladan, et al.
Publicado: (2020) -
Prognostic Impact of Blood MN1 Copy Numbers Before Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia
por: Jentzsch, Madlen, et al.
Publicado: (2019) -
High expression of the stem cell marker GPR56 at diagnosis identifies acute myeloid leukemia patients at higher relapse risk after allogeneic stem cell transplantation with the CD34(+)/CD38(-) population
por: Jentzsch, Madlen, et al.
Publicado: (2020)